Clinical Scorecard: Exploring the Potential Link Between Histamine Intolerance and Fibromyalgia: A Narrative Review of Evidence and Clinical Significance
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Patients with fibromyalgia, particularly those with gastrointestinal symptoms, chronic pruritus, or treatment resistance, with emphasis on the prevalence of gastrointestinal symptoms.
Care Setting
Key Highlights
Clarify the clinical implications of the 74.5% prevalence of DAO deficiency-associated genetic variants.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Monitor symptom severity using specific metrics such as the Fibromyalgia Impact Questionnaire.
Risks
Patient & Prescribing Data
Fibromyalgia patients, especially those with gastrointestinal symptoms
DAO supplementation may lead to significant improvements in pain and overall symptom severity
Clinical Best Practices
Include patient education on histamine intolerance and its potential impact on fibromyalgia symptoms.
A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness
